DÄ internationalArchive37/2007Alternative, Minimally Invasive Treatment of Benign Prostatic Hyperplasia

Review article

Alternative, Minimally Invasive Treatment of Benign Prostatic Hyperplasia

Dtsch Arztebl 2007; 104(37): A-2501

Berges, R; Muschter, R; Höfner, K

For technical reasons, the English full text will be published approximately two weeks after the German print edition has been published.

1. Muschter R: Current status of laser treatment of BPH. Med Laser Appl 2001,16: 5–14.
2. Berges R, Dreikorn K, Hofner K et al.: Leitlinien der Deutschen Urologen zur Therapie des benignen Prostatasyndroms (BPS). Urologe A 2003; 42: 722–38. MEDLINE
3. Muschter R, Whitfield H: Interstitial laser therapy of benign prostatic hyperplasia. Eur Urol 1999; 35: 147–54. MEDLINE
4. Norby B, Nielsen HV, Frimodt-Moller PC: Transurethral interstitial laser coagulation of the prostate and transurethral microwave thermotherapy vs transurethral resection or incision of the prostate: results of a randomized, controlled study in patients with symptomatic benign prostatic hyperplasia. BJU Int 2002, 90: 853–62. MEDLINE
5. Schatzl G, Madersbacher S, Djavan B, Lang T, Marberger M: Two-year results of transurethral resection of the prostate versus four „less invasive“ treatment options. Eur Urol 2000; 37: 695–701. MEDLINE
6. Hoffman RM, MacDonald R, Wilt TJ: Laser prostatectomy for benign prostatic obstruction. Cochrane Database Syst Rev 2004: CD001987. MEDLINE
7. Reich O, Gratzke C, Stief CG: Techniques and long-term results of surgical procedures for BPH. Eur Urol 2006; 49: 970–8. MEDLINE
8. Gilling PJ, Kennett KM, Fraundorfer MR: Holmium laser resection vs transurethral resection of the prostate: results of a randomized trial with 2 years of follow-up. J Endourol 2000; 14: 757–60. MEDLINE
9. Kuntz RM: Current role of lasers in the treatment of benign prostatic hyperplasia (BPH). Eur Urol 2006; 49: 961–9. MEDLINE
10. Boyle P, Robertson C, Vaughan ED, Fitzpatrick JM: A meta-analysis of trials of transurethral needle ablation for treating symptomatic benign prostatic hyperplasia. BJU Int 2004; 94: 83–8. MEDLINE
11. Braun M, Mathers M, Bondarenko B, Engelmann U: Treatment of benign prostatic hyperplasia through transurethral needle ablation (TUNA). Review of the literature and six years of clinical experience. Urol Int 2004; 72: 32–9. MEDLINE
12. Hill B, Belville W, Bruskewitz R et al.: Transurethral needle ablation versus transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia: 5-year results of a prospective, randomized, multicenter clinical trial. J Urol 2004; 171 (6 Pt 1): 2336–40. MEDLINE
13. Zlotta AR, Giannakopoulos X, Maehlum O, Ostrem T, Schulman CC: Long-term evaluation of transurethral needle ablation of the prostate (TUNA) for treatment of symptomatic benign prostatic hyperplasia: clinical outcome up to five years from three centers. Eur Urol 2003, 44: 89–93. MEDLINE
14. Huidobro C, Bolmsjo M, Larson T et al.: Evaluation of microwave thermotherapy with histopathology, magnetic resonance imaging and temperature mapping. J Urol 2004, 171(2 Pt 1): 672–8. MEDLINE
15. Hoffman RM, MacDonald R, Monga M, Wilt TJ: Transurethral microwave thermotherapy vs transurethral resection for treating benign prostatic hyperplasia: a systematic review. BJU Int 2004; 94: 1031–6. MEDLINE
16. Wagrell L, Schelin S, Nordling J et al.: Three-year follow-up of feedback microwave thermotherapy versus TURP for clinical BPH: a prospective randomized multicenter study. Urology 2004; 64: 698–702. MEDLINE
17. Schelin S, Claezon A, Sundin A, Wagrell L: Effects of intraprostatic and periprostatic injections of mepivacaine epinephrine on intraprostatic blood flow during transurethral microwave thermotherapy: correlation with [15O]H2O-PET. J Endourol 2004; 18: 965–70. MEDLINE
18. Kobelt G, Spangberg A, Mattiasson A: The cost of feedback micro-wave thermotherapy compared with transurethral resection of the prostate for treating benign prostatic hyperplasia. BJU Int 2004; 93: 543–8. MEDLINE
19. De La Rosette JJ, Floratos DL, Severens JL, Kiemeney LA, Debruyne FM, Pilar Laguna M: Transurethral resection vs microwave thermotherapy of the prostate: a cost-consequences analysis. BJU Int 2003; 92: 713–8. MEDLINE
e1. Muschter R, Hofstetter A: Interstitial laser therapy outcomes in benign prostatic hyperplasia. J Endourol 1995; 9: 129–35. MEDLINE
e2. Muschter R, de la Rosette JJ, Whitfield H, Pellerin JP, Madersbacher S, Gillatt D: Initial human clinical experience with diode laser interstitial treatment of benign prostatic hyperplasia. Urology 1996; 48: 223–8. MEDLINE
e3. Norby B, Nielsen HV, Frimodt-Moller PC: Transurethral interstitial laser coagulation of the prostate and transurethral microwave thermotherapy vs transurethral resection or incision of the prostate: results of a randomized, controlled study in patients with symptomatic benign prostatic hyperplasia. BJU Int 2002; 90: 853–62. MEDLINE
e4. Kursh ED, Concepcion R, Chan S, Hudson P, Ratner M, Eyre R: Interstitial laser coagulation versus transurethral prostate resection for treating benign prostatic obstruction: a randomized trial with 2-year follow-up. Urology 2003; 61: 573–8. MEDLINE
e5. Costello TG, Crowe H, Costello AJ: Laser prostatectomy versus transurethral resection of the prostate for benign prostatic hypertrophy: comparative changes in haemoglobin and serum sodium. Anaesth Intensive Care 1997; 25: 493–6. MEDLINE
e6. Kabalin JN, Gill HS, Bite G, Wolfe V: Comparative study of laser versus electrocautery prostatic resection: 18-month follow up with complex urodynamic assessment. J Urol 1995; 153: 94–7; discussion 7–8. MEDLINE
e7. Cowles RS, 3rd, Kabalin JN, Childs S et al.: A prospective randomized comparison of transurethral resection to visual laser ablation of the prostate for the treatment of benign prostatic hyperplasia. Urology 1995; 46: 155–60. MEDLINE
e8. Anson K, Nawrocki J, Buckley J et al.: A multicenter, randomized, prospective study of endoscopic laser ablation versus transurethral resection of the prostate. Urology 1995; 46: 305–10. MEDLINE
e9. McAllister WJ, Absalom MJ, Mir K et al.: Does endoscopic laser ablation of the prostate stand the test of time? Five-year results from a multicentre randomized controlled trial of endoscopic laser ablation against transurethral resection of the prostate. BJU Int 2000; 85: 437–9. MEDLINE
e10. Shingleton WB, Terrell F, Renfroe DL, Kolski JM, Fowler JE Jr.: A randomized prospective study of laser ablation of the prostate versus transurethral resection of the prostate in men with benign prostatic hyperplasia. Urology 1999; 54: 1017–21. MEDLINE
e11. Carter A, Sells H, O'Boyle PJ: High-power KTP laser for the treatment of symptomatic benign prostatic enlargement. BJU Int 1999; 83: 857–8. MEDLINE
e12. Tuhkanen K, Heino A, Aaltomaa S, Ala-Opas M: Long-term results of contact laser versus transurethral resection of the prostate in the treatment of benign prostatic hyperplasia with small or moderately enlarged prostates. Scand J Urol Nephrol 2003; 37: 487–93. MEDLINE
e13. Gilling PJ, Cass CB, Malcolm A, Cresswell M, Fraundorfer MR, Kabalin JN: Holmium laser resection of the prostate versus neodymium: yttrium-aluminum-garnet visual laser ablation of the prostate: a randomized prospective comparison of two techniques for laser prostatectomy. Urology 1998; 51: 573–7. MEDLINE
e14. Shingleton WB, Renfroe LD, Kolski JM, Fowler JE Jr.: A randomized prospective study of transurethral electrovaporization vs laser ablation of the prostate in men with benign prostatic hypertrophy. Scand J Urol Nephrol 1998; 32: 266–9. MEDLINE
e15. Keoghane SR, Sullivan ME, Doll HA, Kourambas J, Cranston DW: Five-year data from the Oxford Laser Prostatectomy Trial. BJU Int 2000; 86: 227–8. MEDLINE
e16. Wilson LC, Gilling PJ, Williams A et al.: A randomised trial comparing Holmium laser enucleation versus transurethral resection in the treatment of prostates larger than 40 grams: Results at 2 years. Eur Urol 2006; 50: 569–73. MEDLINE
e17. Hill B, Belville W, Bruskewitz R et al.: Transurethral needle ablation versus transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia: 5-year results of a prospective, randomized, multicenter clinical trial. J Urol 2004; 171 (6 Pt 1): 2336–40. MEDLINE
e18. Chandrasekar P, Virdi JS: Transurethral needle ablation of the prostate (TUNA) – a prospective study, six year follow-up. J Urol 2001; 165(Suppl 1): Abstract.
e19. Schatzl G, Madersbacher S, Djavan B, Lang T, Marberger M: Two-year results of transurethral resection of the prostate versus four „less invasive“ treatment options. Eur Urol 2000, 37: 695–701. MEDLINE
e20. Roehrborn CG, Burkhard FC, Bruskewitz RC et al.: The effects of transurethral needle ablation and resection of the prostate on pressure flow urodynamic parameters: analysis of the United States randomized study. J Urol 1999, 162: 92–7. MEDLINE
e21. Bruskewitz R, Issa MM, Roehrborn CG et al.: A prospective, randomized 1-year clinical trial comparing transurethral needle ablation to transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia. J Urol 1998; 159: 1588–93; discussion 93–4. MEDLINE
e22. Cimentepe E, Unsal A, Saglam R: Randomized clinical trial comparing transurethral needle ablation with transurethral resection of the prostate for the treatment of benign prostatic hyperplasia: results at 18 months. J Endourol 2003; 17: 103–7. MEDLINE
e23. Ramon J, Lynch TH, Eardley I et al.: Transurethral needle ablation of the prostate for the treatment of benign prostatic hyperplasia: a collaborative multicentre study. Br J Urol 1997; 80: 128–34; discussion 34–5. MEDLINE
e24. Kahn SA, Alphonse P, Tewari A, Narayan P: An open study on the efficacy and safety of transurethral needle ablation of the prostate in treating symptomatic benign prostatic hyperplasia: the University of Florida experience. J Urol 1998; 160: 1695–700. MEDLINE
e25. Namiki K, Shiozawa H, Tsuzuki M, Mamiya Y, Matsumoto T, Miki M: Efficacy of transurethral needle ablation of the prostate for the treatmentof benign prostatic hyperplasia. Int J Urol 1999; 6: 341–5. MEDLINE
e26. Hill B, Belville W, Bruskewitz R, Issa M, Perez-Marrero R, Roehrborn C, Terris M, Naslund M: Transurethral needle ablation versus transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia: 5-year results of a prospective, randomized, multicenter clinical trial. J Urol 2004; 6: 2336–40.
e27. Bergamaschi F, Manzo M, Autieri G, Corrada P, Campo B: Five years experience using transurethral needle ablation (TUNA) in 204 BPH patients. J Urol 2000; 163(Suppl 1): Abstract.
e28. Zlotta AR, Giannakopoulos X, Maehlum O, Ostrem T, Schulman CC: Long-term evaluation of transurethral needle ablation of the prostate (TUNA) for treatment of symptomatic benign prostatic hyperplasia: clinical outcome up to five years from three centers. Eur Urol 2003; 44: 89–93. MEDLINE
e29. Murai M, Tachibana M, Miki M, Shiozawa H, Hirao Y, Okajima E: Transurethral needle ablation of the prostate: an initial Japanese clinical trial. Int J Urol 2001; 8: 99–105. MEDLINE
e30. Rosario DJ, Woo H, Potts KL, Cutinha PE, Hastie KJ, Chapple CR: Safety and efficacy of transurethral needle ablation of the prostate for symptomatic outlet obstruction. Br J Urol 1997; 80: 579–86. MEDLINE
e31. Steele GS, Sleep DJ: Transurethral needle ablation of the prostate: a urodynamic based study with 2-year followup. J Urol 1997; 158: 1834–8. MEDLINE
e32. De La Rosette JJ, Floratos DL, Severens JL, Kiemeney LA, Debruyne FM, Pilar Laguna M: Transurethral resection vs microwave thermotherapy of the prostate: a cost-consequences analysis. BJU Int 2003; 92: 713–8. MEDLINE
e33. Floratos DL, Kiemeney LA, Rossi C, Kortmann BB, Debruyne FM, de La Rosette JJ: Long-term followup of randomized transurethral microwave thermotherapy versus transurethral prostatic resection study. J Urol 2001; 165: 1533–8. MEDLINE
e34. Cavarretta L, Scremin E, Cucciarre G, Todeschini M, Novella G, Tasca A: High-energy microwave thermotherapy in the treatment of benign prostatic hyperplasia. Urol Int 2003; 71: 10–5. MEDLINE
e35. Selvaggio O, Ditonno P, Battaglia M, Bettocchi C, Saracino A, Palazzo S: Long term results (4 years) of high-energy transurethral microwave. Eur Urol 2003; 2(102A).
e36. Gravas S, Laguna P, Kiemeney LA, de la Rosette JJ: Durability of 30-minute high-energy transurethral microwave therapy for treatment of benign prostatic hyperplasia: a study of 213 patients with and without urinary retention. Urology 2007; 96: 854–8. MEDLINE
e37. D'Ancona FC, Francisca EA, Witjes WP, Welling L, Debruyne FM, De La Rosette JJ: Transurethral resection of the prostate vs high-energy thermotherapy of the prostate in patients with benign prostatic hyperplasia: long-term results. Br J Urol 1998; 81: 259–64. MEDLINE
e38. Ahmed M, Bell T, Lawrence WT, Ward JP, Watson GM: Transurethral microwave thermotherapy (Prostatron version 2.5) compared with transurethral resection of the prostate for the treatment of benign prostatic hyperplasia: a randomized, controlled, parallel study. Br J Urol 1997; 79: 181–5. MEDLINE
e39. Dahlstrand C, Walden M, Geirsson G, Pettersson S: Transurethral microwave thermotherapy versus transurethral resection for symptomatic benign prostatic obstruction: a prospective randomized study with a 2-year follow-up. Br J Urol 1995; 76: 614–8. MEDLINE
e40. Wagrell L, Schelin S, Nordling J et al.: Three-year follow-up of feedback microwave thermotherapy versus TURP for clinical BPH: a prospective randomized multicenter study. Urology 2004; 64: 698–702. MEDLINE
e41. Alivizatos G, Ferakis N, Mitropoulos D, Skolarikos A, Livadas K, Kastriotis I: Feedback microwave thermotherapy with the prostalund compact device for obstructive benign prostatic hyperplasia: 12-month response rates and complications. J Endourol 2005; 19: 72–8. MEDLINE
e42. David RD, Grunberger I, Shore N, Swierzewski SJ 3rd: Multicenter initial U.S. experience with coretherm-monitored feedback transurethral microwave thermotherapy for individualized treatment of patients with symptomatic benign prostatic hyperplasia. J Endourol 2004; 18: 682–5. MEDLINE
e43. Gravas S, Laguna MP, de la Rosette JJ: Efficacy and safety of intraprostatic temperature-controlled microwave thermotherapy in patients with benign prostatic hyperplasia: results of a prospective, open-label, single-center study with 1-year follow-up. J Endourol 2003; 17: 425–30. MEDLINE
e44. Albala DM, Turk TM, Fulmer BR et al.: Periurethral transurethral microwave thermotherapy for the treatment of benign prostatic hyperplasia: an interim 1-year safety and efficacy analysis using the thermatrx TMx-2000. Tech Urol 2000; 6: 288–93. MEDLINE
e45. Yokoyama T, Tsugawa M, Nagai A, Kumon H: High-energy transurethral microwave thermotherapy in patients with benign prostatic hyperplasia: comparative study between 30-and 60-minute single treatments. Acta Med Okayama 2004; 5: 151–6. MEDLINE
e46. Thalmann GN, Mattei A, Treuthardt C, Burkhard FC, Studer UE: Transurethral microwave therapy in 200 patients with a minimum followup of 2 years: urodynamic and clinical results. J Urol 2002; 167: 2496–501. MEDLINE
e47. Djavan B, Seitz C, Roehrborn CG et al.: Targeted transurethral microwave thermotherapy versus alpha-blockade in benign prostatic hyperplasia: outcomes at 18 months. Urology 2001; 57: 66–70. MEDLINE

Info

Specialities